24 In this study, the proportion of children being born small for gestational age was lower in the vitamin B 12 group than in the placebo group (25% vs 34%)
In a pilot trial of NAD+ intravenous infusion in healthy adults, subjects receiving 750 mg of NAD+ over 6 hours reported no negative symptoms at all, and there were no vital sign abnormalities or serious laboratory derangements compared to placebo
These products are not drugs, foods, cosmetics, diagnostic products, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use
Careful storage supports reliable injection preparation for patient safety
In addition to protecting damaged neurons, NAD+ precursors have shown promise in delaying the effects of several neurodegenerative diseases making this a must have treatment